logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
C

Chuangui Song

fujian medical university

9H指数
37论文数
208被引数
收录论文 16
发表时间
logo
A novel prognostic signature identifies MFAP4 as a tumor suppressor linking the tumor microenvironment to PI3K/AKT signaling in triple-negative breast cancer一种新的预后特征将MFAP4鉴定为一种肿瘤抑制因子，将肿瘤微环境与三阴性乳腺癌中的PI3K/AKT信号联系起来
errFRONTIERS IN IMMUNOLOGY
IF5.9
err2025-12-10
err0
PREAI
errYu, Xiaoqin; Li, Xiaofen; Luo, Shiping; Song, Chuangui
err分享
err收藏
Crosstalk between Lipid Droplets and Autophagy in Cancer: A Nexus for Therapeutic Targeting脂质滴与自噬在癌症中的串扰：一个治疗靶向的枢纽
errPharmacological Research
IF10.5
err2025-11-04
err0
errOAAI
errXiaofen Li; Jiwen Zhang; Shiping Luo; Xiaoqin Yu; Chuangui Song
err分享
err收藏
Machine learning model for predicting tertiary lymphoid structures and treatment response in triple-negative breast cancer预测三阴性乳腺癌三级淋巴结构和治疗反应的机器学习模型
errnpj Precision Oncology
IF8
err2025-07-01
err0
PREAI
errYidan Lin; Yushuai Yu; Qing Wang; Kaiyan Huang; Shukai Guo; Jie Zhang; Yihui He; Xin Yu; Jiwen Zhang; Fan Meng; Shicong Tang; Junhui Yuan; Chuangui Song
err分享
err收藏
Abemaciclib combined with endocrine therapy as adjuvant treatment for hormone-receptor-positive, HER2-, high-risk early breast cancer: 5-year Chinese population analysis of the phase III randomized monarchE studyAbemaciclib联合内分泌治疗作为激素受体阳性，HER2-高危早期乳腺癌的辅助治疗: III期随机monarchE研究的5年中国人群分析
errTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
err2024-10-23
err0
errOAAI
errZhang, Qingyuan; Shen, Kunwei; Song, Chuan-gui; Ouyang, Quchang; Liu, Zhenzhen; Liu, Qiang; Feng, Jifeng; Chiu, Joanne W. Y.; Tang, Jinhai; Jiang, Zefei; Tseng, Ling-Ming; Wang, Xiaojia; Yang, Liu; Qian, Chenxi; Shao, Zhimin
err分享
err收藏
Does T1c-2N0-1M0 triple negative breast cancer derive a benefit from neoadjuvant chemotherapy?
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errZhang, Jie; Yu, Yushuai; Chen, Weiwei; Fu, Wenfen; Chen, Ruiliang; Yi, Jialu; Song, Chuangui
err分享
err收藏
Efficacy and Safety of First-line Therapy in Patients with HER-2 positive Advanced Breast Cancer: A network Meta-analysis of Randomized Controlled Trials
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errWang, Junxiao; Yu, Yushuai; Zhang, Jie; Song, Chuangui
err分享
err收藏
Discovery of proliferation essential gene signature and ACTL6A as potential biomarker for predicting prognosis and neoadjuvant therapy response in triple-positive breast cancer
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errLi, Xiaofen; Fu, Wenfen; Luo, Shiping; Zhang, Jie; Wang, Qingshui; Song, Chuangui
err分享
err收藏
The trade-off of post-mastectomy radiotherapy usage for the breast cancer patients aged 70 years or older: a study based on SEER database
errBMC GERIATRICS
IF3.8
err2023-10-06
err1
errOAAI
errLin, Jingyi; Luo, Shiping; Zhang, Jie; Song, Chuangui
err分享
err收藏
Epidemiology and a Predictive Model of Prognosis Index Based on Machine Learning in Primary Breast Lymphoma: Population-Based Study
errJMIR PUBLIC HEALTH AND SURVEILLANCE
IF3.9
err2023-06-08
err2
errOAAI
errYu, Yushuai; Xu, Zelin; Shao, Tinglei; Huang, Kaiyan; Chen, Ruiliang; Yu, Xiaoqin; Zhang, Jie; Han, Hui; Song, Chuangui
err分享
err收藏
Single-cell Analysis of KN026 in Combination with KN046 in Treating Patients with Advanced HER2-positive Breast Cancer
errCANCER RESEARCH
IF16.6
err2023-03-01
err0
PREAI
errLiu, Jieqiong; Liao, Jianyou; Tian, Zhenluan; Wang, Jien; Song, Chuangui
err分享
err收藏
An iron metabolism and immune related gene signature for the prediction of clinical outcome and molecular characteristics of triple-negative breast cancer铁代谢和免疫相关基因标记预测三阴性乳腺癌的临床结局和分子特征
errBMC CANCER
IF3.4
err2022-06-07
err7
errOAAI
errLi, Xiao-Fen; Fu, Wen-Fen; Zhang, Jie; Song, Chuan-Gui
err分享
err收藏
The impact of chemotherapy and survival prediction by machine learning in early Elderly Triple Negative Breast Cancer (eTNBC): a population based study from the SEER database通过机器学习对早期老年三阴性乳腺癌 (eTNBC) 的化疗和生存预测的影响: 来自SEER数据库的基于人群的研究
errBMC GERIATRICS
IF3.8
err2022-04-01
err20
errOAAI
errHuang, Kaiyan; Zhang, Jie; Yu, Yushuai; Lin, Yuxiang; Song, Chuangui
err分享
err收藏
Quality of life results from OlympiA: A phase III, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)-adjuvant chemotherapy in patients with germline BRCA1/2 mutations and high-risk HER-2 negative early breast cancer
errCANCER RESEARCH
IF16.6
err2022-02-15
err2
PREAI
errGanz, Patricia A.; Bandos, Hanna; Spanic, Tanja; Friedman, Sue; Muller, Volkmar; Kummel, Sherko; Delaloge, Suzette; Brain, Etienne; Toi, Masakazu; Yamauchi, Hideko; de Duenas, Eduardo-Martinez; Armstrong, Anne; Im, Seock-Ah; Song, Chuangui; Zheng, Hong; Sarosiek, Tomasz; Sharma, Priyanka; Rossi, Giovanna; Rastogi, Priya; Fielding, Anitra; Gelber, Richard D.; Campbell, Christine; Garber, Judy E.; Geyer, Charles E., Jr.; Tutt, Andrew N. J.
err分享
err收藏
Preliminary safety and efficacy results of KN046 (an anti-PD-L1/CTLA-4 bispecific antibody) in combination with KN026 (a HER2-targeted bispecific antibody) in patients with metastatic HER2-positive breast cancer: A phase II trial
errCANCER RESEARCH
IF16.6
err2022-02-15
err1
PREAI
errLiu, Jieqiong; Song, Chuangui; Wang, Xiangcai; Ni, Mingli; Wang, Xujuan; Chen, Lei; Yang, Hongwei; Zhao, Rusen; Xu, Ting; Shen, Lin
err分享
err收藏
Efficacy and safety of neoadjuvant therapy for HER2-positive early breast cancer: a network meta-analysis
errTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
err2021-04-03
err12
errOAAI
errZhang, Jie; Yu, Yushuai; Lin, Yuxiang; Kang, Shaohong; Lv, Xinyin; Liu, Yushan; Lin, Jielong; Wang, Jun; Song, Chuangui
err分享
err收藏
Different Clinicopathological Characteristics and Prognostic Factors for Occult and Non-occult Breast Cancer: Analysis of the SEER Database
errFRONTIERS IN ONCOLOGY
IF3.3
err2020-08-19
err14
errOAAI
errHuang, Kai-Yan; Zhang, Jie; Fu, Wen-Fen; Lin, Yu-Xiang; Song, Chuan-Gui
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
R
Richard D. Gelber
H 指数: 133 · 论文数: 594
J
Judy E. Garber
H 指数: 130 · 论文数: 973
P
Patricia A. Ganz
H 指数: 129 · 论文数: 894
王军 封面图
王军 (Jun Wang)
H 指数: 122 · 论文数: 1.6K
A
Andrew Tutt
H 指数: 103 · 论文数: 781
查看更多